Omzo review
The banner says $179 for semaglutide and $279 for tirzepatide. Those are first-month prices. The Terms and Conditions — the only place this seller lists what the months after cost — put every follow-up month at $299 and $399. Read Omzo on those numbers, not the banner.
then $299/mo ongoing
- Six-factor Editors' Rating
- Public signup walkthrough
This review draws on the provider’s public pricing, terms and disclosures. No one on this desk is your clinician.
Omzo at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored Omzo
Each score comes out of Omzo's published pricing, disclosures and oversight, and the six combine into the 51/100 Editors' Rating on our weighted six-factor framework. A commission never changes a provider's score.
The headline rate obscures a plan requirement or a hidden step-up.
Fair value once you read past any teaser rate or plan structure.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Oversight and lab support fall short of the best we track — the review below says exactly where.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Primary source
- The company's own site
The follow-up prices are in its Terms and Conditions — nowhere else on the site carries them. Compounded semaglutide runs $299 a month after a $179 first month; tirzepatide $399 after a first month the homepage puts at $279 and the Terms at $259. Each package covers the consultation, prescription, medication and shipping. The banner's "starting at $179" is 40% under the standing rate, and nothing on the homepage says so. Brand-name medication carries no published price; the site says it does not sell or ship Ozempic or Wegovy. In its favor, the same document is franker about compounding than most: it states that compounded drugs are not FDA-approved, that the agency does not review them for safety, efficacy or quality, and that no equivalence to an approved drug is claimed. It serves all 50 states, holds a LegitScript seal, names no operating company or compounding pharmacy, and has no FDA warning letter on file.
What to expect when you sign up
We walked Omzo's public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
These signup observations are from . The flow and offers may have changed; use the current pricing and terms in this review.
- 1The signup button keeps you on Omzo's own site
- 2The homepage shows only the first-month price: $179 for semaglutide, $279 for tirzepatide
- 3The price for every month after the first appears only in its Terms and Conditions
What we noticed
- The homepage price is a first-month figure; the standing monthly rate ($299 or $399) is printed only in the Terms
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $179 → $299 | Follow-up months — the standing rateThe Terms publish "Follow-Up Consultation - GLP-1 ... Priced at $299"; the first month is "Originally priced at $179," matching the homepage's "Starting at $179." |
| Compounded tirzepatide | $279 → $399 | Follow-up months — the standing rate"Follow-Up Consultation - GLP-1 + GIP ... Priced at $399." The homepage says "Starting at $279" for the first month; the Terms list the first month at $259. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Omzo's public disclosures at last review and change often; confirm the current number on Omzo's own site.
What we like
- An itemized schedule exists in its Terms, with a first-month and a follow-up price for each medication
- Consultation, prescription, medication, shipping and ongoing support are all named as included
- Refreshingly blunt about compounding: not FDA-approved, not reviewed for safety or quality, no equivalence claimed
- Serves all 50 states and says it ships nowhere else
- LegitScript certified
The caveats
- $179 on the banner against $299 for every month after the first — a 40% jump you only see in the Terms
- The homepage's tirzepatide figure, $279, doesn't match the $259 first-month price in its own Terms
- The only place the follow-up prices live is a legal page nothing links you to
- No brand-name option with a published price; its site says it does not sell or ship Ozempic or Wegovy
- No operating company named in any legal page
- The compounding pharmacy is never named
Omzo in short
Omzo advertises $179 to start, but the regular rate is about $299/month — that second number is the one to budget for. Its strongest marks from us are for value for a family budget; its weakest are for price transparency.
What Omzo actually costs
- Compounded semaglutide — Follow-up months — the standing rate: $179 to start, then $299/mo
- Compounded tirzepatide — Follow-up months — the standing rate: $279 to start, then $399/mo
For comparison, the typical price we see is about $196/month — Omzo sits above it. Over a year at that rate, you'd spend about $3,588.
What's included: the clinician consult, the medication, and shipping.
What Omzo prescribes
Omzo prescribes semaglutide and tirzepatide — the two GLP-1 medications with the strongest evidence. If insulin resistance is part of your story (PCOS, a history of gestational diabetes), tirzepatide is often the better fit, and you won't need a new provider to try it. These are compounded versions from a licensed pharmacy, which keeps the price down, but compounded GLP-1s are not FDA-approved finished products the way Wegovy and Zepbound are.
Signing up with Omzo
Every state is covered. Prices are posted before the intake starts — you can compare without filling in a single form.
Similar providers
Close in price to Omzo, and worth comparing:
- Mint Medical Clinic — $299/mo, semaglutide and tirzepatide
- Prime Health — $299/4 wks, semaglutide and tirzepatide, same price at every dose
- yourEra — $79/mo, semaglutide and tirzepatide, same price at every dose
Is Omzo right for you?
Worth a look if…
- You may want to switch between semaglutide and tirzepatide later on.
- Your family might move — it serves every state.
- You want to see the price before you share any health information.
Probably not for you if…
- You specifically want an FDA-approved brand pen with its own pregnancy and breastfeeding labeling.
- Budget is tight — it costs more than most of the providers we've reviewed.
- You want one flat price at every dose — compare CoreAge Rx, a featured partner.
Can you trust it?
With any compounded GLP-1, ask which licensed pharmacy fills the prescription and what exactly is in the vial. Our Editors' Rating methodology explains how we score oversight.
Tell your own clinician if you are pregnant, breastfeeding or trying to conceive before starting treatment. Using medication for weight loss is not recommended while pregnant. Breastfeeding decisions require the specific product’s labeling and an individual assessment, rather than a blanket rule across every GLP-1 formulation.
What to ask Omzo first
- What does the price become after the first month?
- Can I pause the plan if we decide to try for a baby?
Should you sign up?
Omzo costs more than most, so it has to earn the difference — its strongest card is value for a family budget. If you're still choosing, compare it with CoreAge Rx, a featured partner.
The bottom line for mothers
Best for: Someone who will open the Terms before the checkout, and compare on $299 rather than on the banner.
Alternatives to Omzo
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge RxCoreAge RxFeatured partner
The one program on our list whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit MEDGm
A rare combination on our list: four dispensing pharmacies named outright, a named prescribing partner in OpenLoop, and genuine brand-name access to Wegovy, Zepbound and Ozempic beside a compounded line. Month to month, compounded semaglutide is $299 as a weekly injection or $369 as a daily tablet, and tirzepatide $399 as an injection, with a cheaper first month and lower rates if you prepay up to a year. The gaps are on the brand side and in the fine print. The three brand products are quoted as a membership plus a medication cost that is never published, and the membership itself appears at two different figures on one page, $99 against Zepbound and Wegovy and $171 against Ozempic. The terms also provide that a provider may switch your molecule and that continuing to stay enrolled is your consent, with the charges carrying on. It says plainly that people in its advertising may be actors or artificial intelligence.
- Visit Embody
A flat price at every dose — $299/mo semaglutide, $349/mo tirzepatide, currently cut to $79 and $129 by a time-limited sale — but real Trustpilot reviews say the signup price hasn't always held, and payment happens before the eligibility review.
Providers like Omzo
Keep comparing Omzo
Head-to-head & alternatives
Ranked boards
- The 2026 guide to the best GLP-1 for moms
- Best GLP-1 for women — PCOS & menopause
- Best GLP-1 for first-timers & beginners
- Cheapest GLP-1 without insurance
- Best GLP-1 after baby — postpartum providers ranked
- Best GLP-1 with insurance & coverage help
- Best GLP-1 providers for PCOS
- Best GLP-1 for perimenopause & menopause
- Cheapest tirzepatide online, month to month
- Cheapest semaglutide online, month to month
Omzo, answered
- How much does Omzo cost?
- When we last checked, the lowest eligible ongoing compounded price at Omzo worked out to an estimated $299 per calendar month. This is a monthly budget equivalent; the actual charge and billing interval may differ. Confirm today's all-in invoice amount, renewal dates and dose-specific rate before signing up.
- Is Omzo safe to use while breastfeeding?
- Discuss breastfeeding with your prescriber before starting treatment through Omzo. Advice depends on the exact medicine and formulation, your treatment needs and your infant's circumstances; limited milk data do not establish infant safety. Oral and injectable products can have different labeling, and a compounded preparation needs its own assessment. Tell the clinician if you are pregnant or planning pregnancy so treatment and any stopping interval can be planned individually.
- Does Omzo offer both semaglutide and tirzepatide?
- Omzo discloses both semaglutide and tirzepatide options. Confirm the specific product, formulation, current availability in your state and eligibility with the provider; a listed menu does not mean either medicine is appropriate for you.
- Where does Omzo rank for mothers?
- Omzo takes 51/100 in our Editors' Rating, placing it #221. Six factors chosen for mothers feed that number. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect Omzo's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.